On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Fate Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Fate Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Fate Therapeutics (United States)?

ScholarIQrecord summary

Fate Therapeutics (United States) is a research organisation in San Diego, US. OpenAlex records 588 works and 45,401 citations for it. 431 researchers list it as their most recent affiliation.

How many works does Fate Therapeutics (United States) have?

ScholarIQindexed works

Fate Therapeutics (United States) has 588 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Fate Therapeutics (United States) have?

ScholarIQcitation count

Fate Therapeutics (United States) has 45,401 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Fate Therapeutics (United States)?

ScholarIQresearcher count

Fate Therapeutics (United States) has 431 researchers in the ScholarIQ index.

What is the average h-index at Fate Therapeutics (United States)?

ScholarIQavg h-index

Fate Therapeutics (United States) has an average h-index of 21 in OpenAlex.

What is the ROR of Fate Therapeutics (United States)?

ScholarIQror

The ROR for Fate Therapeutics (United States) is on the source record.

What is the OpenAlex record for Fate Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Fate Therapeutics (United States) is on the source record.

Who are the most-cited researchers behind Fate Therapeutics (United States)?

ScholarIQtop researchers by citations
1
Daniel Shoemaker · CAR-T cell therapy research
55 works17,750 citations

What are the most-cited papers on Fate Therapeutics (United States)?

ScholarIQmost cited works
Functional profiling of the Saccharomyces cerevisiae genome
Guri Giaever, Angela Chu, Li Ni, Carla J. Connelly, Linda Riles, Steeve Véronneau, Sally Dow, Ankuta Lucau-Danila, Keith M. Anderson, Bruno André, Adam P. Arkin, Anna Astromoff, Mohamed El Bakkoury, Rhonda Bangham, Rocí­o Benito, Sophie Brachat, Stefano Campanaro, Matt Curtiss, Karen Davis, Adam M. Deutschbauer, Karl-Dieter Entian, Patrick Flaherty, Françoise Foury, David Garfinkel, Mark Gerstein, Deanna Gotte, Ulrich Güldener, Johannes H. Hegemann, Svenja Hempel, Zelek S. Herman, Daniel F. Jaramillo, Diane Kelly, Steven L. Kelly, Peter Kötter, Darlene LaBonte, David C. Lamb, Ning Lan, Hong Liang, Hong Liao, Lucy Liu, C. Luo, Marc Lussier, Rong Mao, P Ménard, Siew Loon Ooi, José Luis Revuelta, Christopher J. Roberts, Matthias Rose, Petra Ross‐Macdonald, Bart Scherens, Greg Schimmack, Brenda Shafer, Daniel Shoemaker, Sharon Sookhai-Mahadeo, Reginald Storms, Jeffrey N. Strathern, Giorgio Valle, Marleen Voet, Guido Volckaert, Ching-Yun Wang, Teresa R. Ward, Julie Wilhelmy, Elizabeth A. Winzeler, Yonghong Yang, Grace S. Yen, Elaine M. Youngman, Kexin Yu, Howard Bussey, Jef D. Boeke, M Snyder, Peter Philippsen, Ronald W. Davis, Mark Johnston
Nature. 20024,537 Citations
Functional Characterization of the <i>S. cerevisiae</i> Genome by Gene Deletion and Parallel Analysis
Elizabeth A. Winzeler, Daniel Shoemaker, Anna Astromoff, Hong Liang, Keith M. Anderson, Bruno André, Rhonda Bangham, Rocí­o Benito, Jef D. Boeke, Howard Bussey, Angela Chu, Carla J. Connelly, Karen Davis, Fred S. Dietrich, Sally Dow, Mohamed El Bakkoury, Françoise Foury, Stephen Friend, Erik Gentalen, Guri Giaever, Johannes H. Hegemann, Ted Jones, Michael T. Laub, Hong Liao, Nicole Liebundguth, David J. Lockhart, Anca Lucau‐Danila, Marc Lussier, Nasiha M’Rabet, P Ménard, Michael Mittmann, Chai Pai, Corinne Rebischung, José Luis Revuelta, Linda Riles, Christopher J. Roberts, Petra Ross‐Macdonald, Bart Scherens, M Snyder, Sharon Sookhai-Mahadeo, Reginald Storms, Steeve Véronneau, Marleen Voet, Guido Volckaert, Teresa R. Ward, Robert Wysocki, Grace S. Yen, Kexin Yu, Katja Zimmermann, Peter Philippsen, Mark Johnston, Ronald W. Davis
Science. 19994,040 Citations

How much of the research on Fate Therapeutics (United States) is open access?

ScholarIQopen access share
0%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
0%
Closed
100%

Related on ScholarIQ

470M+ articles · 14-day free trial